Status:
UNKNOWN
Outcome and Prognostic Factors of Surgical Management of Scalp AVMs.
Lead Sponsor:
Assiut University
Conditions:
Cirsoid Aneurysm
Eligibility:
All Genders
Phase:
NA
Brief Summary
Scalp arteriovenous malformations (AVMs) are rarely encountered vascular scalp anomalies that represent 8% of all AVMs. Different terms are being used to describe the vascular anomalies of the scalp i...
Detailed Description
Patients with scalp AVMs are usually presented with scalp swelling, and cosmetic concerns along with other presentations including headache, pain, tinnitus, audible bruits, palpable thrills, and hemor...
Eligibility Criteria
Inclusion
- Patients with scalp AVMs confirmed by various imaging techniques. AVMs of the scalp will include: cirsoid aneurysm, serpentinum aneurysm, racemosum aneurysm, plexiform angioma, arteriovenous fistula, high flow shunts and arteriovenous malformations.
- Age group: any age group.
- Aetiology: congenital, traumatic, or any.
Exclusion
- High risk patients or unfit for surgery.
- Patients refused surgery, or scheduled for endovascular intervention.
Key Trial Info
Start Date :
July 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT05341336
Start Date
July 1 2022
End Date
December 31 2023
Last Update
February 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut University Hospitals
Asyut, Egypt, 71515